Health CarePharmaceuticals & Biotechnology
  • Price (HKD)8.96
  • Today's Change0.19 / 2.17%
  • Shares traded10.57m
  • 1 Year change55.56%
  • Beta0.4090
Data delayed at least 15 minutes, as of Oct 20 2017 09:09 BST.
More ▼

Events & Activity

  • 1177:HKG price reached a new 52-week high of 9.12 at 15:02 BST
  • 1177:HKG price moved over +1.38% to 8.80
  • 1177:HKG trading volume exceeds daily average by +20.11%

Key statistics

Sino Biopharmaceutical Ltd (1177:HKG) set a new 52-week high during Thursday's trading session when it reached 9.19. Over this period, the share price is up 58.02%.
52-week range
5.20Nov 15 20169.19Oct 19 2017
Markit short selling activity
Previous close8.77
Average volume12.03m
Shares outstanding7.41bn
Free float4.27bn
P/E (TTM)29.25
Market cap65.00bn HKD
EPS (TTM)0.2998
Annual div (ADY)0.065
Annual div yield (ADY)0.74%
Div ex-dateSep 12 2017
Div pay-dateSep 29 2017
Data delayed at least 15 minutes, as of Oct 20 2017 09:09 BST.
More ▼
© Thomson Reuters Click for restrictions
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.